Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shephard Mpofu
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results From the Phase 3 FUTURE 1 Study
ACR Open Rheumatology
Related publications
FRI0494 Secukinumab Provides Rapid and Sustained Pain Relief in Psoriatic Arthritis: 2-Year Results From the Future 2 Study
THU0369 Secukinumab 150mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis With High Retention Rate: 3-Year Results From Phase Iii Trial, Measure 2
Certolizumab Pegol Is Associated With Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes From the Rapid-Psa Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Interleukin-17inhibition With Secukinumab Improves Sudomotor Dysfunction in Psoriatic Arthritis
International Journal of Pharmacy and Pharmaceutical Sciences
Pharmacology
Pharmaceutical Science
Improved Patient-Reported Outcomes in Patients With Psoriatic Arthritis Treated With Abatacept: Results From a Phase 3 Trial
Arthritis Research & Therapy
SAT0480 Comparative Effectiveness of Secukinumab and Infliximab in Psoriatic Arthritis Assessed by Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data
Review: Pharmacotherapy Provides Minimal Improvements in the Neuropsychiatric Symptoms of Dementia
Evidence-Based Mental Health
Psychiatry
Mental Health
AB0794 Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis: Results From Two Phase 3 Studies
Real-World Data on Secukinumab Use for Psoriatic Arthritis and Ankylosing Spondylitis
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
